3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
8
Carcinoma, Non-Small-Cell Lung
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasm, Residual
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Neoplasms
2
Lymphoma, Mantle-Cell
2
Colorectal Neoplasms
2
Uterine Cervical Neoplasms
1
Smoldering Multiple Myeloma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Plasma Cell
1
Nasopharyngeal Carcinoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Plasma Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Chromosome 17 deletion
1
Carcinoma
1
Burkitt Lymphoma
1
Interventions
Filgrastim
13
Peripheral Blood Stem Cell Transplantation
10
Melphalan
9
Ifosfamide
9
Etoposide
9
Cyclophosphamide
8
Thiotepa
6
Carboplatin
6
Busulfan
6
Radiotherapy
5
Doxorubicin
5
Vincristine
3
Topotecan
3
Temozolomide
3
Docetaxel
3
trioctyl phosphine oxide
2
temsirolimus
2
etoposide phosphate
2
Transplantation
2
Surgical Procedures, Operative
2
Stem Cell Transplantation
2
Radiotherapy, Intensity-Modulated
2
Microarray Analysis
2
Mesna
2
Granulocyte Colony-Stimulating Factor
2
Gemcitabine
2
Dexrazoxane
2
Cisplatin
2
Bone Marrow Transplantation
2
Amifostine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neuroectodermal Tumors, Primitive, Peripheral
×
Maintenance
×
Clear all
NCT03011528
2025-11-21
CombinaiR3
Institut Curie
Phase 2
Completed
45 enrolled